Physician profile
Danil Rybalko
NPI 1164841631
$31,790.86
in general payments reported to CMS, 2019-2025
19 companies · $3,508 in 2025
The $3,508 reported for 2025 was more than what 79% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $2,665 · 2021: $4,300 · 2022: $3,441 · 2023: $737 · 2024: $17K · 2025: $3,508.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $15K · Food and Beverage: $3,693 · Consulting Fee: $1,467 · Travel and Lodging: $1,226.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $15,000.00 |
| Food and Beverage | $3,692.65 |
| Consulting Fee | $1,466.67 |
| Travel and Lodging | $1,225.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acumed LLC | $17,940.59 | 2020-2025 | Acumed, Innate Implant, Nanophix Implant |
| Medwest Associates | $4,926.54 | 2020-2023 | |
| Trimed, INC. | $2,205.11 | 2020-2022 | |
| Arthrex, INC. | $1,692.12 | 2021-2025 | |
| Stryker Corporation | $1,620.65 | 2020-2025 | T2 Alpha, T2, Aequalis Perform+ |
| Becton, Dickinson and Company | $1,466.67 | 2024 | |
| Lightbody Medical Technologies INC | $885.89 | 2025 | |
| Skeletal Dynamics INC | $271.83 | 2025 | Geminus, Ijs, Implate |
| Catalyst Orthoscience | $246.60 | 2022-2023 | R1 Reverse Total Shoulder, Csr & R1 Reverse Total Shoulder Systems |
| Integra Lifesciences Corporation | $112.93 | 2022-2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Acell, INC. | $110.67 | 2020 | |
| Depuy Synthes Sales INC. | $73.51 | 2024 | Na, Healix Knotless Peek, Dynacord |
| Globus Medical, INC. | $68.88 | 2024 | Distal Radius II, Proximal Humerus Strut, Headless Compression Screw |
| Linvatec Corporation | $47.71 | 2024-2025 | Biobrace 23mm |
| Kerecis Limited | $30.28 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $27.67 | 2025 | Proclaim |
| Vertex Pharmaceuticals Incorporated | $25.64 | 2025 | |
| Amgen INC. | $21.63 | 2024 | Krystexxa |
| Musculoskeletal Transplant Foundation INC. | $15.94 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Danil Rybalko listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.